PharmaShots

CRISPR Therapeutics and KSQ Therapeutics Cross Licenses their IP Rights to Facilitate Cell Therapy Programs in Oncology

October 15, 2019October 15, 2019Shiwani Sharma

Shots: CRISPR to gain access to KSQ intellectual property (IP) for editing certain novel gene targets in its allogeneic oncology cell therapy programs [Read More...]

Bayer Signs a Clinical Collaboration Agreement with BMS and Ono to Evaluate Dual Regimen for Metastatic Colorectal Cancer

July 18, 2019July 18, 2019Tuba Khan

Shots: Bayer, BMS and Ono collaborate to evaluate the combination of Bayer’s Stivarga (regorafenib) with BMS & Ono’s Opdivo (nivolumab) vs regorafenib in [Read More...]

Janssen(J&J) Signs an Exclusive Worldwide License Agreement with MeiraGTx for its Gene Therapy Candidates

February 1, 2019June 14, 2019Shiwani Sharma

Shots: Janssen to get exclusive WW license rights to develop & commercialize certain clinical candidates in MeiraGTx’s inherited retinal disease pipeline. Janssen also [Read More...]

Domain Therapeutics Signs Research and License Agreement with Boehringer Ingelheim (BI) for G-Protein Coupled Receptors (GPCRs)

December 6, 2018June 14, 2019Shiwani Sharma

Shots: Domain to receive upfront, milestones, and royalties on sales from Boehringer Ingelheim The focus of the agreement is to discover & develop [Read More...]